Cite Filings / MLYS / 0002012383-26-000775

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Mineralys Therapeutics, Inc. Filed 2026-01-21 Acc 0002012383-26-000775

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-05 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-21 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-20 144 Sale of Securities
2026-01-20 4 Chief Medical Officer sold 416 shares at $32.10 ($13,354)
2026-01-15 4 Chief Medical Officer sold 19,076 shares at an average $32.66 ($623,115)
2026-01-14 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…